S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
5 Tips I Wish I Knew Before Starting My Business
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Live Updates: Russia-Ukraine War
Too Soon: 3 Reasons to Wait on DocuSign Stock
Why I Sued the Gov’t – And What I Recommend Now (Ad)
WTO predicts trade growth to slow next year amid crises
OPEC+ makes big oil cut to boost prices; pump costs may rise
The 3-Stock Retirement Blueprint (Ad)
Stocks slump as Wall Street’s big rally fades, yields rise
Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear
S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
5 Tips I Wish I Knew Before Starting My Business
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Live Updates: Russia-Ukraine War
Too Soon: 3 Reasons to Wait on DocuSign Stock
Why I Sued the Gov’t – And What I Recommend Now (Ad)
WTO predicts trade growth to slow next year amid crises
OPEC+ makes big oil cut to boost prices; pump costs may rise
The 3-Stock Retirement Blueprint (Ad)
Stocks slump as Wall Street’s big rally fades, yields rise
Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear
S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
5 Tips I Wish I Knew Before Starting My Business
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Live Updates: Russia-Ukraine War
Too Soon: 3 Reasons to Wait on DocuSign Stock
Why I Sued the Gov’t – And What I Recommend Now (Ad)
WTO predicts trade growth to slow next year amid crises
OPEC+ makes big oil cut to boost prices; pump costs may rise
The 3-Stock Retirement Blueprint (Ad)
Stocks slump as Wall Street’s big rally fades, yields rise
Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear
S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
5 Tips I Wish I Knew Before Starting My Business
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Live Updates: Russia-Ukraine War
Too Soon: 3 Reasons to Wait on DocuSign Stock
Why I Sued the Gov’t – And What I Recommend Now (Ad)
WTO predicts trade growth to slow next year amid crises
OPEC+ makes big oil cut to boost prices; pump costs may rise
The 3-Stock Retirement Blueprint (Ad)
Stocks slump as Wall Street’s big rally fades, yields rise
Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear
FRA:HNR1

Hannover Rück - HNR1 Stock Forecast, Price & News

€159.50
+0.85 (+0.54%)
(As of 10/5/2022 12:00 AM ET)
Add
Compare
Today's Range
€158.45
€159.75
50-Day Range
€135.95
€163.30
52-Week Range
€94.75
€116.37
Volume
74,288 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
€175.15
HNR1 stock logo

About Hannover Rück (FRA:HNR1) Stock

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The company offers property, casualty, facultative, catastrophe XL, structured reinsurance, and insurance-linked securities. It also provides risk solutions for agricultural, livestock, and bloodstock businesses; aviation and space business; and marine and offshore energy business, as well as credit, surety, and political risks reinsurance products. In addition, the company offers group and individual credit life, enhanced annuities, group life and health, and Takaful reinsurance products; and risk solutions in the areas of critical illness, disability, health, longevity, long term care, mortality, and morbidity. Further, it provides various financial solutions, including new-business financing; monetization of embedded value; reserve and solvency relief; and divestiture of non-core businesses. The company was formerly known as Hannover Rückversicherung AG and changed its name to Hannover Rück SE in March 2013. The company was founded in 1966 and is headquartered in Hanover, Germany. Hannover Rück SE is a subsidiary of Talanx AG.

Receive HNR1 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hannover Rück and its competitors with MarketBeat's FREE daily newsletter.

HNR1 Stock News Headlines

Hannover Rück SE (HNR1.DE)
Hannover Rück: gute Voraussetzungen für einen Bounce!
Hannover Re 1H Net Pft EUR648.7M
Hannover Rück-Aktie: Das sieht vielversprechend aus
Hannover Rück-Aktie gewinnt 1,69 Prozent
Aktie von Hannover Rück legt um 1,73 Prozent zu
Kursverluste für die Hannover Rück-Aktie
Leichte Zugewinne bei der Hannover Rück-Aktie
Hannover Rück: Robust durch die Krise
See More Headlines
Receive HNR1 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hannover Rück and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Insurance - Reinsurance
Sub-Industry
N/A
Sector
Finance
CIK
N/A
Fax
N/A
Employees
3,346
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
€175.15
High Stock Price Forecast
€205.00
Low Stock Price Forecast
€140.00
Forecasted Upside/Downside
+9.8%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Jean-Jacques Henchoz (Age 58)
    CEO & Chairman of the Exec. Board
    Comp: $1.88M
  • Mr. Clemens Jungsthofel (Age 52)
    CFO & Member of Exec. Board
    Comp: $836.4k
  • Dr. Michael Pickel (Age 62)
    Member of the Exec. Board
    Comp: $1.12M
  • Dr. Klaus Wilhelm Miller (Age 62)
    Member of the Exec. Board
    Comp: $1.03M
  • Mr. Claude Jacques Chèvre (Age 55)
    Member of the Exec. Board
    Comp: $1.08M
  • Mr. Sven Althoff (Age 53)
    Member of the Exec. Board
    Comp: $1.25M
  • Ms. Silke Sehm (Age 53)
    Member of Exec. Board
    Comp: $924.3k
  • Ms. Julia Hartmann
    Sr. IR Mang.- Corp. Communications
  • Mr. Karl Steinle
    Head of Corp. Communications
  • Michael Eberhardt
    Managing Director of Hannover Re Australian Branch













HNR1 Stock - Frequently Asked Questions

What is Hannover Rück's stock price forecast for 2022?

0 Wall Street research analysts have issued 1 year price objectives for Hannover Rück's stock. Their HNR1 share price forecasts range from €140.00 to €205.00. On average, they anticipate the company's share price to reach €175.15 in the next year. This suggests a possible upside of 10.4% from the stock's current price.
View analysts price targets for HNR1
or view top-rated stocks among Wall Street analysts.

How have HNR1 shares performed in 2022?

Hannover Rück's stock was trading at €167.15 on January 1st, 2022. Since then, HNR1 stock has decreased by 5.1% and is now trading at €158.65.
View the best growth stocks for 2022 here
.

What other stocks do shareholders of Hannover Rück own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hannover Rück investors own include American Tower (AMT), Walt Disney (DIS), QUALCOMM (QCOM), AmerisourceBergen (ABC), Allstate (ALL), BlackRock (BLK), Cummins (CMI), Quest Diagnostics (DGX), DocuSign (DOCU) and Deutsche Wohnen (DWNI).

What is Hannover Rück's stock symbol?

Hannover Rück trades on the FRA under the ticker symbol "HNR1."

What is Hannover Rück's stock price today?

One share of HNR1 stock can currently be purchased for approximately €158.65.

How many employees does Hannover Rück have?

The company employs 3,346 workers across the globe.

How can I contact Hannover Rück?

Hannover Rück's mailing address is Karl-Wiechert-Allee 50, HANNOVER, 30625, Germany. The official website for the company is www.hannover-rueck.de. The company can be reached via phone at +49-511-56040.

This page (FRA:HNR1) was last updated on 10/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.